Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center

被引:0
|
作者
Luís Alberto de Pádua Covas Lage
Felipe Faganelli Caboclo dos Santos
Débora Levy
Frederico Rafael Moreira
Samuel Campanelli Freitas Couto
Hebert Fabrício Culler
Renata de Oliveira Costa
Vanderson Rocha
Juliana Pereira
机构
[1] Sao Paulo University (FMUSP),Department of Hematology, Hemotherapy and Cell Therapy of Medicine School, Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco
[2] Sao Paulo University (FMUSP),Immuno
[3] Sao Paulo University (FMUSP),Hematology (LIM
[4] Sao Paulo University (FMUSP),31)
[5] Centro Universitário Lusíadas,Department of Hematology, Hemotherapy and Cell Therapy of Medicine School
[6] Pró-Sangue Foundation (Sao Paulo Blood Bank),Department of Hematology, Hemotherapy and Cell Therapy of Medicine School, Laboratory of Medical Investigation 19 (LIM
[7] Oxford University,19)
来源
BMC Cancer | / 20卷
关键词
Splenic marginal zone lymphoma; Prognostic factors; Splenectomy; Rituximab; Poor-resource settings;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 1 条
  • [1] Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center
    de Padua Covas Lage, Luis Alberto
    Caboclo dos Santos, Felipe Faganelli
    Levy, Debora
    Moreira, Frederico Rafael
    Freitas Couto, Samuel Campanelli
    Culler, Hebert Fabricio
    Costa, Renata de Oliveira
    Rocha, Vanderson
    Pereira, Juliana
    BMC CANCER, 2020, 20 (01)